Fahad Mawlood
- General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
Training in Regenerative Geriatric Medicine at Nordic University
Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
Training in Regenerative Medicine at Nordic University
EXPERIENCE
Founder of the biotechnological institute “Bioplenum S.A de C.V”
Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent
ACCOLADES
HemoFenix France representative in Mexico and Latin America
Kimicor Pharma representative at the Italian laboratory in Mexico
Krebs International, General Director for the company located in Bulgaria
General Director for Immunotherapy for México A.C. foundation
Read more
EDUCATION
Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
Training in Regenerative Geriatric Medicine at Nordic University
Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
Training in Regenerative Medicine at Nordic University
EXPERIENCE
Founder of the biotechnological institute “Bioplenum S.A de C.V”
Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent
ACCOLADES
HemoFenix France representative in Mexico and Latin America
Kimicor Pharma representative at the Italian laboratory in Mexico
Krebs International, General Director for the company located in Bulgaria
General Director for Immunotherapy for México A.C. foundation